n,n-dimethylarginine has been researched along with linagliptin in 1 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (linagliptin) | Trials (linagliptin) | Recent Studies (post-2010) (linagliptin) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 598 | 149 | 554 |
| Protein | Taxonomy | n,n-dimethylarginine (IC50) | linagliptin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.3 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.2967 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.0008 | |
| Prolyl endopeptidase FAP | Mus musculus (house mouse) | 0.37 | |
| Prolyl endopeptidase FAP | Homo sapiens (human) | 0.0799 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diessel, S; Forst, T; Jahnke, J; Kapitza, C; Michelson, G | 1 |
1 trial(s) available for n,n-dimethylarginine and linagliptin
| Article | Year |
|---|---|
Microvascular effects of the inhibition of dipeptidylpeptidase IV by linagliptin in nondiabetic hypertensive patients.
Topics: Aged; Arginine; Arterial Pressure; C-Reactive Protein; Cyclic GMP; Cystatin C; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypertension; Linagliptin; Male; Microvessels; Middle Aged; Regional Blood Flow; Retinal Vessels; Transforming Growth Factor beta1 | 2016 |